Co-Authors
This is a "connection" page, showing publications co-authored by Eleanor Barnes and Paul Klenerman.
Connection Strength
1.677
-
Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8+ T Cells by Persistent Viruses and Vaccines. Cell Rep. 2018 Apr 17; 23(3):768-782.
Score: 0.191
-
The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes. Vaccine. 2018 01 04; 36(2):313-321.
Score: 0.186
-
No evidence to support a role for Helicobacter pylori infection and plasminogen binding protein in autoimmune pancreatitis and IgG4-related disease in a UK cohort. Pancreatology. 2017 May - Jun; 17(3):395-402.
Score: 0.178
-
Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati. PLoS One. 2013; 8(8):e66749.
Score: 0.138
-
T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet. 2005 Jan 22-28; 365(9456):327-9.
Score: 0.076
-
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 2004 Sep; 127(3):924-36.
Score: 0.074
-
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern. Nat Commun. 2021 08 17; 12(1):5061.
Score: 0.060
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. Lancet HIV. 2021 08; 8(8):e474-e485.
Score: 0.059
-
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell. 2021 08 05; 184(16):4220-4236.e13.
Score: 0.059
-
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nat Commun. 2021 04 06; 12(1):2055.
Score: 0.059
-
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. Nat Commun. 2021 03 29; 12(1):1951.
Score: 0.059
-
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera. Cell. 2021 04 29; 184(9):2348-2361.e6.
Score: 0.058
-
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. 2021 04 15; 184(8):2201-2211.e7.
Score: 0.058
-
Autophagy in T cells from aged donors is maintained by spermidine and correlates with function and vaccine responses. Elife. 2020 12 15; 9.
Score: 0.057
-
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat Immunol. 2020 11; 21(11):1336-1345.
Score: 0.056
-
SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020; 5:181.
Score: 0.056
-
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel. Wellcome Open Res. 2020; 5:139.
Score: 0.055
-
Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort. BMC Infect Dis. 2018 Sep 14; 18(1):461.
Score: 0.049
-
Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing. Antiviral Res. 2017 Oct; 146:139-145.
Score: 0.046
-
Immune phenotype and function of natural killer and T cells in chronic hepatitis C patients who received a single dose of anti-MicroRNA-122, RG-101. Hepatology. 2017 07; 66(1):57-68.
Score: 0.045
-
Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology. 2011 May; 53(5):1446-54.
Score: 0.029
-
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology. 2009 Oct; 50(4):1017-29.
Score: 0.026